Food allergies represent one of the most significant and rapidly growing public health challenges in contemporary medicine, affecting an estimated two hundred fifty million people worldwide and generating a clinical and economic burden that extends far beyond the immediate medical management of acute reactions. Unlike food intolerances, which involve non-immune-mediated adverse reactions to food components and are typically dose-dependent and less immediately dangerous, true food allergies involve specific immune system responses to food proteins that can produce reactions ranging from mild localized discomfort to life-threatening anaphylaxis. The psychological, nutritional, social, and economic consequences of living with significant food allergies are profound and must be addressed as integral components of comprehensive food allergy management alongside the medical management of reactions and the minimization of accidental exposures.
The epidemiology of food allergies has changed dramatically over the past three decades, with prevalence rates in Westernized countries having roughly doubled or tripled depending on the allergen and population studied. This rapid increase in prevalence exceeds any plausible contribution from genetic change and points to environmental, dietary, and microbiological factors as the primary drivers of the food allergy epidemic. The most compelling hypothesis, supported by a growing body of experimental and epidemiological evidence, is the dual allergen exposure hypothesis, which proposes that early oral exposure to food allergens through the diet during infancy promotes the development of immunological tolerance, while cutaneous exposure to the same allergens through an impaired skin barrier promotes sensitization and allergy development. The dramatic expansion of food allergy prevalence has created urgent clinical demand for better diagnostic tools, effective preventive strategies, and therapeutic options that go beyond strict avoidance.
Immunological Mechanisms of Food Allergy
The immunological mechanisms underlying food allergies share the fundamental framework of IgE-mediated hypersensitivity that characterizes other allergic conditions, with food allergen proteins serving as the antigenic triggers that drive sensitization and elicit subsequent allergic reactions. Food allergen proteins that cause IgE-mediated food allergy tend to share certain structural characteristics that favor their recognition as foreign and dangerous by the immune system: they are typically relatively resistant to heat and digestive enzyme degradation, allowing them to maintain their allergenic structure through cooking and gastrointestinal digestion and present intact to the mucosal immune system of the gut. The identification of these structural features has informed the development of hypoallergenic food preparations and the rational design of immunotherapy protocols.
Sensitization to food allergens can occur through the gastrointestinal route in the context of dysregulated mucosal immunity, through the skin in the context of atopic dermatitis and impaired barrier function, or through the respiratory tract in some cases. Once sensitization has occurred, subsequent exposure to even tiny quantities of the allergen through ingestion can trigger the cross-linking of IgE antibodies on mast cells throughout the gastrointestinal tract, skin, respiratory tract, and cardiovascular system, producing the multi-organ manifestations of systemic allergic reactions. The severity of allergic reactions to foods is influenced by multiple factors including the dose of allergen ingested, the route and speed of absorption, the degree of IgE sensitization, the activation state of mast cells at the time of exposure, and host factors including exercise, concurrent alcohol consumption, and the use of medications that alter gastrointestinal absorption or mast cell reactivity.
Non-IgE-mediated food allergies represent a distinct category of immune-mediated adverse food reactions whose mechanisms differ fundamentally from classical IgE-mediated food allergy and whose clinical presentations, diagnostic approaches, and management strategies therefore also differ. Food protein-induced enterocolitis syndrome, food protein-induced allergic proctocolitis, and food protein-induced enteropathy are the major non-IgE-mediated food allergic conditions and present with predominantly gastrointestinal symptoms. These conditions are most prevalent in infancy and early childhood and are often triggered by cow’s milk and soy proteins. Unlike IgE-mediated food allergy, non-IgE-mediated food allergies do not carry the risk of immediate anaphylaxis and typically resolve with age as the infant’s gastrointestinal immune system matures.
Major Food Allergens and Clinical Presentations
The eight major food allergens responsible for the vast majority of food-allergic reactions in the United States and many other countries are peanuts, tree nuts, milk, eggs, wheat, soy, fish, and shellfish. Each of these allergens has distinctive clinical characteristics reflecting the nature of its allergenic proteins, the population most commonly affected, and its typical clinical course. Peanut allergy is the most feared of the common food allergies because of its association with severe and potentially fatal anaphylactic reactions, its tendency to persist lifelong rather than resolving in childhood, and the extreme difficulty of avoiding peanut exposure given its ubiquitous presence as an ingredient and processing contaminant in commercially manufactured foods.
Tree nut allergy, which encompasses allergy to cashews, walnuts, almonds, pecans, pistachios, hazelnuts, Brazil nuts, and other tree-derived nuts, is also strongly associated with severe reactions and lifelong persistence. Many tree nut-allergic individuals are allergic to multiple tree nut species, though cross-reactivity between different tree nuts varies and does not justify blanket restriction of all tree nuts without individual allergen testing. Milk allergy in infancy is the most common food allergy in the first year of life and typically presents with a combination of gastrointestinal symptoms including vomiting, diarrhea, and failure to thrive alongside dermatological manifestations. The majority of infants with milk allergy develop tolerance by early childhood, which distinguishes it from peanut and tree nut allergy.
Egg allergy is the second most common food allergy in infancy and early childhood and typically resolves by mid-childhood in the majority of affected children. The tolerance of baked egg, in which the allergenic proteins in egg are extensively denatured by high-temperature cooking in a baked matrix, by a substantial proportion of egg-allergic children has led to the development of baked egg oral immunotherapy protocols that may accelerate the development of complete egg tolerance. Shellfish allergy, including allergy to crustaceans such as shrimp, crab, and lobster, and mollusks such as clams, oysters, and squid, is one of the most common food allergies in adults and tends to persist lifelong. The primary allergen in crustacean shellfish, tropomyosin, is a muscle protein that cross-reacts between different crustacean species but not between crustaceans and fish.
Diagnosis of Food Allergy
The accurate diagnosis of food allergy is essential for appropriate management and requires a systematic approach that integrates the clinical history with objective testing and, in many cases, oral food challenge procedures. The clinical history is the foundation of food allergy diagnosis, providing information about the timing of reaction onset relative to food ingestion, the nature and severity of symptoms, the reproducibility of reactions with the same food, and the foods most plausibly implicated based on the reaction pattern. A reaction occurring within thirty to sixty minutes of ingesting a specific food and involving multiple organ systems, such as urticaria and vomiting or lip swelling and difficulty breathing, is highly suggestive of IgE-mediated food allergy and warrants objective allergen testing.
Skin prick testing and serum allergen-specific IgE measurement are the objective diagnostic tests most commonly used in the initial evaluation of suspected food allergy. Both tests measure the degree of sensitization to specific food allergens but cannot reliably predict the severity of future reactions, and neither test alone is sufficient to diagnose clinically relevant food allergy. Positive results indicate sensitization but must be interpreted in the clinical context, as sensitization without clinical reactivity is common, particularly for soy and wheat, where the majority of IgE-positive individuals tolerate the food without symptoms. Component-resolved diagnostic testing, which measures IgE to specific molecular components within a food rather than to the whole food extract, provides improved precision in distinguishing primary sensitization from cross-reactive sensitization and in predicting the risk of systemic reactions.
The double-blind, placebo-controlled oral food challenge remains the gold standard for definitive diagnosis of food allergy and is essential in cases where the clinical history and initial allergy testing leave diagnostic uncertainty. In an oral food challenge, the patient ingests gradually increasing doses of the suspected allergen under direct medical supervision with appropriate emergency treatment available, allowing real-time assessment of tolerance versus reactivity. Open and single-blind food challenges are more commonly performed in clinical practice as they are less resource-intensive while still providing clinically valuable diagnostic information in most situations where significant placebo effects are not anticipated.
Management and Emerging Therapies
Strict avoidance of the identified food allergen or allergens has historically been the only available management strategy for food allergy, supplemented by the prescription of injectable epinephrine auto-injectors for emergency management of accidental exposure reactions. Epinephrine is the first-line treatment for anaphylaxis, reversing the life-threatening cardiovascular and respiratory manifestations of severe allergic reactions through its combined alpha and beta adrenergic effects, and all patients with food allergy at risk for anaphylaxis must carry epinephrine auto-injectors at all times and be trained in their correct use.
Oral immunotherapy for food allergy, in which patients are exposed to gradually increasing doses of the food allergen under medical supervision over a period of months to years, has emerged as the first disease-modifying treatment for food allergy and received regulatory approval for peanut allergy in 2020. Peanut oral immunotherapy using a pharmaceutical grade peanut flour preparation has demonstrated the ability to desensitize the majority of treated peanut-allergic children to doses that would have previously caused severe reactions, substantially reducing the risk of accidental exposure reactions. The treatment requires a long-term commitment to daily maintenance dosing following the desensitization phase, and reactions during treatment are common, necessitating careful patient selection and ongoing medical supervision.